Acorah Software Products - Accounts Production 18.1.170 false true false 1 October 2024 30 September 2025 30 September 2025 15932481 Dr Mohammed Amin Dr Samuel Ghani iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15932481 2024-09-30 15932481 2025-09-30 15932481 2024-10-01 2025-09-30 15932481 frs-core:ShareCapital 2025-09-30 15932481 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 15932481 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 15932481 frs-bus:SmallEntities 2024-10-01 2025-09-30 15932481 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 15932481 frs-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 15932481 frs-core:CostValuation 2024-09-30 15932481 frs-core:AdditionsToInvestments 2025-09-30 15932481 frs-core:CostValuation 2025-09-30 15932481 frs-core:ProvisionsForImpairmentInvestments 2024-09-30 15932481 frs-core:ProvisionsForImpairmentInvestments 2025-09-30 15932481 frs-bus:Director1 2024-10-01 2025-09-30 15932481 frs-bus:Director2 2024-10-01 2025-09-30 15932481 frs-countries:EnglandWales 2024-10-01 2025-09-30
Registered number: 15932481
Facial Holdco Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2025
DKR Chartered Accountants
36 Lichfield Street
Walsall
West Midlands
WS1 1TJ
Facial Holdco Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2

Page 1
Facial Holdco Ltd
Balance Sheet
As At 30 September 2025
Balance Sheet
Registered number: 15932481

| 2025
--- | ---
| Notes | £ | £
FIXED ASSETS
Investments | 4 |  | 98
|  |  | 98
CURRENT ASSETS
Cash at bank and in hand |  | 2 |
|  | 2 |
NET CURRENT ASSETS (LIABILITIES) |  |  | 2
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 100
NET ASSETS |  |  | 100
CAPITAL AND RESERVES
Called up share capital | 5 |  | 100
SHAREHOLDERS' FUNDS |  |  | 100

For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr Mohammed Amin Director
1st June 2026

The notes on page 2 form part of these financial statements.
Page 1
Page 2
Facial Holdco Ltd
Notes to the Financial Statements
For The Year Ended 30 September 2025
Notes to the Financial Statements
1. General Information
Facial Holdco Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15932481 . The registered office is 36 Lichfield Street, Walsall, West Midlands, WS1 1TJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Merger accounting
During the year ended 30th September 2025, the Company became the parent undertaking of Facial Aesthetic & Cosmetic Enhancement Clinic Limited by way of a share-for-share exchange. The shareholders of the subsidiary exchanged their shares for shares in the Company, resulting in the Company acquiring 100% of the issued share capital of Facial Aesthetic & Cosmetic Enhancement Clinic Limited.
The transaction represents a group reconstruction under common control. Accordingly, the investment in the subsidiary has been accounted for using merger accounting principles in accordance with FRS 102.
The investment has been recorded at the nominal value of the shares issued in exchange for the shares acquired. No fair value adjustments have been made to the underlying assets and liabilities of the subsidiary.
Any difference arising between the nominal value of the shares issued and the nominal value of the shares acquired has been recognised in equity within other reserves.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
4. Investments

| Subsidiaries
--- | ---
| £
Cost or Valuation
As at 1 October 2024 | -
Additions | 98
As at 30 September 2025 | 98
Provision
As at 1 October 2024 | -
As at 30 September 2025 | -
Net Book Value
As at 30 September 2025 | 98
As at 1 October 2024 | -

5. Share Capital

| 2025
--- | ---
| £
Allotted, Called up and fully paid | 100

Page 2